Ipilimumab was safe and effective in two patients with metastatic melanoma and end-stage renal disease

Ludimila Cavalcante, Asim Amin, Jose Lutzky

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

This is a unique report of two cases of patients with end-stage renal disease on hemodialysis, receiving ipilimumab for treatment of metastatic melanoma, as there is a paucity of safety and efficacy data in this patient subgroup.

Original languageEnglish (US)
Pages (from-to)47-50
Number of pages4
JournalCancer Management and Research
Volume7
DOIs
StatePublished - Jan 19 2015
Externally publishedYes

Keywords

  • Advanced melanoma
  • Hemodialysis
  • Report of cases

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Ipilimumab was safe and effective in two patients with metastatic melanoma and end-stage renal disease'. Together they form a unique fingerprint.

Cite this